Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes

ClinicalTrials.gov ID: NCT00427154

Public ClinicalTrials.gov record NCT00427154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 11:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect of Inhaled Pre-Prandial Human Insulin Plus Metformin & Glimepiride Versus Rosiglitazone Plus Metformin & Glimepiride on HbA1c in Subjects With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in the United States of America (USA). This trial will compare the changes in HbA1c after 26 weeks of inhaled insulin or rosiglitazone treatment, both in combination with metformin and glimepiride.

Study identification

NCT ID
NCT00427154
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
227 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 10, 2007 (Actual)
Primary completion
Mar 11, 2008 (Actual)
Completion
Mar 11, 2008 (Actual)
Last update posted
Sep 5, 2018

2007 – 2008

United States locations

U.S. sites
103
U.S. states
34
U.S. cities
98
Facility City State ZIP Site status
Novo Nordisk Investigational Site Hueytown Alabama 35023 —
Novo Nordisk Investigational Site Ozark Alabama 36360 —
Novo Nordisk Investigational Site Tuscaloosa Alabama 35406 —
Novo Nordisk Investigational Site Vestavia Hills Alabama 35209 —
Novo Nordisk Investigational Site Tucson Arizona 85741 —
Novo Nordisk Investigational Site Concord California 94520 —
Novo Nordisk Investigational Site Escondido California 92025 —
Novo Nordisk Investigational Site Fresno California 93720 —
Novo Nordisk Investigational Site Huntington Beach California 92646 —
Novo Nordisk Investigational Site La Jolla California 92037 —
Novo Nordisk Investigational Site Orange California 92869 —
Novo Nordisk Investigational Site Poway California 92064 —
Novo Nordisk Investigational Site Roseville California 95661 —
Novo Nordisk Investigational Site Sacramento California 95821 —
Novo Nordisk Investigational Site San Diego California 92103 —
Novo Nordisk Investigational Site Santa Barbara California 93105 —
Novo Nordisk Investigational Site Temecula California 92591 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site Colorado Springs Colorado 80904 —
Novo Nordisk Investigational Site Waterbury Connecticut 06708 —
Novo Nordisk Investigational Site Boca Raton Florida 33433 —
Novo Nordisk Investigational Site Clearwater Florida 33759 —
Novo Nordisk Investigational Site Hialeah Florida 33010 —
Novo Nordisk Investigational Site Hollywood Florida 33021 —
Novo Nordisk Investigational Site Lake Mary Florida 32746 —
Novo Nordisk Investigational Site Marianna Florida 32446 —
Novo Nordisk Investigational Site Melbourne Florida 32901 —
Novo Nordisk Investigational Site Merritt Island Florida 32953 —
Novo Nordisk Investigational Site Miami Florida 33136 —
Novo Nordisk Investigational Site Palm Harbor Florida 34684 —
Novo Nordisk Investigational Site Pembroke Pines Florida 33029 —
Novo Nordisk Investigational Site Vero Beach Florida 32960 —
Novo Nordisk Investigational Site West Palm Beach Florida 33401 —
Novo Nordisk Investigational Site Athens Georgia 30606 —
Novo Nordisk Investigational Site Atlanta Georgia 30318 —
Novo Nordisk Investigational Site Atlanta Georgia 30342 —
Novo Nordisk Investigational Site Augusta Georgia 30912-3152 —
Novo Nordisk Investigational Site Dunwoody Georgia 30338 —
Novo Nordisk Investigational Site Powder Springs Georgia 30127 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Suwanee Georgia 30024 —
Novo Nordisk Investigational Site Tucker Georgia 30084 —
Novo Nordisk Investigational Site Honolulu Hawaii 96814 —
Novo Nordisk Investigational Site Boise Idaho 83702 —
Novo Nordisk Investigational Site Chicago Illinois 60607 —
Novo Nordisk Investigational Site Peoria Illinois 61615 —
Novo Nordisk Investigational Site Springfield Illinois 62711 —
Novo Nordisk Investigational Site Lafayette Indiana 47904 —
Novo Nordisk Investigational Site Des Moines Iowa 50314 —
Novo Nordisk Investigational Site Shawnee Mission Kansas 66204 —
Novo Nordisk Investigational Site Topeka Kansas 66606 —
Novo Nordisk Investigational Site Wichita Kansas 67205 —
Novo Nordisk Investigational Site Lexington Kentucky 40503 —
Novo Nordisk Investigational Site Scarborough Maine 04074 —
Novo Nordisk Investigational Site Baltimore Maryland 21201 —
Novo Nordisk Investigational Site Marlborough Massachusetts 01752 —
Novo Nordisk Investigational Site Springfield Massachusetts 01199 —
Novo Nordisk Investigational Site Jackson Mississippi 39216 —
Novo Nordisk Investigational Site Chesterfield Missouri 63017 —
Novo Nordisk Investigational Site Jefferson City Missouri 65109 —
Novo Nordisk Investigational Site Kansas City Missouri 64111 —
Novo Nordisk Investigational Site St Louis Missouri 63141 —
Novo Nordisk Investigational Site Billings Montana 59101 —
Novo Nordisk Investigational Site Omaha Nebraska 68114 —
Novo Nordisk Investigational Site Las Vegas Nevada 89109 —
Novo Nordisk Investigational Site Berlin New Jersey 08009 —
Novo Nordisk Investigational Site Cherry Hill New Jersey 08034 —
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648 —
Novo Nordisk Investigational Site Staten Island New York 10301 —
Novo Nordisk Investigational Site Syracuse New York 13210 —
Novo Nordisk Investigational Site Asheville North Carolina 28803 —
Novo Nordisk Investigational Site Charlotte North Carolina 28209 —
Novo Nordisk Investigational Site Greenville North Carolina 27834 —
Novo Nordisk Investigational Site High Point North Carolina 27262 —
Novo Nordisk Investigational Site Cincinnati Ohio 45245 —
Novo Nordisk Investigational Site Cleveland Ohio 44115 —
Novo Nordisk Investigational Site Cleveland Ohio 44122 —
Novo Nordisk Investigational Site Dayton Ohio 45406 —
Novo Nordisk Investigational Site Dayton Ohio 45439 —
Novo Nordisk Investigational Site Clinton Oklahoma 73601 —
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73104-5020 —
Novo Nordisk Investigational Site Medford Oregon 97504-8491 —
Novo Nordisk Investigational Site Altoona Pennsylvania 16602 —
Novo Nordisk Investigational Site Beaver Pennsylvania 15009 —
Novo Nordisk Investigational Site Norristown Pennsylvania 19401 —
Novo Nordisk Investigational Site Greer South Carolina 29651 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37404 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37411 —
Novo Nordisk Investigational Site Clarksville Tennessee 37043 —
Novo Nordisk Investigational Site Kingsport Tennessee 37660 —
Novo Nordisk Investigational Site Arlington Texas 76014 —
Novo Nordisk Investigational Site Dallas Texas 75230 —
Novo Nordisk Investigational Site Dallas Texas 75231 —
Novo Nordisk Investigational Site Houston Texas 77030 —
Novo Nordisk Investigational Site Hurst Texas 76054 —
Novo Nordisk Investigational Site Lewisville Texas 75067 —
Novo Nordisk Investigational Site San Antonio Texas 78229 —
Novo Nordisk Investigational Site Arlington Virginia 22204 —
Novo Nordisk Investigational Site Norfolk Virginia 23502 —
Novo Nordisk Investigational Site Richmond Virginia 23249 —
Novo Nordisk Investigational Site Warrenton Virginia 20186 —
Novo Nordisk Investigational Site Renton Washington 98057 —
Novo Nordisk Investigational Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00427154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 5, 2018 · Synced Nov 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00427154 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →